Effect of mutation in active site residue Trp209 to Val, Leu, Ile and Pro on the catalytic activity and affinity for some benzenesulfonamides of human carbonic anhydrase II

Human carbonic anhydrase II (hCA II) enzyme was firstly expressed using a pET-SUMO expression vector in Escherichia coli and the recombinant enzyme was purified using nickel (Ni2+) affinity chromatography. The substitutions of Trp 209 with four amino acid (Val, Leu, Ile, and Pro) in the hydrophobic pocket of hCA II were conducted using site-directed mutagenesis. The p-nitrophenyl esterase activity of hCA II variants correlates with the hydrophobicity and size of residue, suggesting that the hydrophobic character of this residue is important for catalysis. The Trp 209 was forecast as an important residue and was exposed to computational mutagenesis. This forecast was confirmed experimentally by producing hCA II mutants and determining the resulting affinities towards some benzenesulfonamides. These mutations in the hydrophobic pocket of the enzyme active site decreased the protein expression of hCA II in E. coli, causing the formation of insoluble protein aggregates in many cases. Our findings demonstrated that the Trp 209 in hCA II plays an important role in the folding process and the valine residues are very compatible for the hydrophobic region in the active cavity of this isoenzyme. These mutant proteins will lead to a better understanding of structural functions and drug-based studies in the future.

PDF

___

Alexander RS, Nair SK, Christianson DW (1991). Engineering the hydrophobic pocket of carbonic anhydrase-II. Biochemistry 30: 11064-11072.
Alp C, Ozsoy S, Alp NA, Erdem D, Gultekin MS, Kufrevioglu OI, Senturk M, Supuran CT (2012). Sulfapyridine-like benzenesulfonamide derivatives as inhibitors of carbonic anhydrase isoenzymes I, II and VI. J Enzym Inhib Med Ch 27: 818-824.
Casini A, Scozzafava A, Mincione F, Menabuoni L, Ilies MA, Supuran CT (2000). Carbonic anhydrase inhibitors: water-soluble 4-sulfamoylphenylthioureas as topical intraocular pressurelowering agents with long-lasting effects. J Med Chem 43: 4884-4892.
Cecchi A, Winum JY, Innocenti A, Vullo D, Montero JL, Scozzafava A, Supuran CT (2004). Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides derived from 4-isothiocyanato-benzolamide. Bioorg Med Chem Lett 14: 5775-5780.
Domsic JF, Avvaru BS, Kim CU, Gruner SM, Agbandje-McKenna M, Silverman DN, McKenna R (2008). Entrapment of carbon dioxide in the active site of carbonic anhydrase II. J Biol Chem 283: 30766-30771.
Ekinci D, Ceyhun SB, Senturk M, Erdem D, Kufrevioglu OI, Supuran CT (2011). Characterization and anions inhibition studies of an alpha-carbonic anhydrase from the teleost fish Dicentrarchus labrax. Bioorgan Med Chem 19: 744-748.
Elleby B, Sjoblom B, Lindskog S (1999). Changing the efficiency and specificity of the esterase activity of human carbonic anhydrase II by site-specific mutagenesis. Eur J Biochem 262: 516-521.
Fierke CA, Calderone TL, Krebs JF (1991). Functional consequences of engineering the hydrophobic pocket of carbonic anhydrase II. Biochemistry 30: 11054-11063.
Fisher SZ, Tu C, Bhatt D, Govindasamy L, Agbandje-McKenna M, McKenna R, Silverman DN (2007). Speeding up proton transfer in a fast enzyme: kinetic and crystallographic studies on the effect of hydrophobic amino acid substitutions in the active site of human carbonic anhydrase II. Biochemistry 46: 3803-3813.
Fisher Z, Boone CD, Biswas SM, Venkatakrishnan B, Aggarwal M, Tu C, Agbandje-McKenna M, Silverman D, McKenna R (2012). Kinetic and structural characterization of thermostabilized mutants of human carbonic anhydrase II. Protein Eng Des Sel 25: 347-355.
Fisher Z, Prada JAH, Tu C, Duda D, Yoshioka C, An HQ, Govindasamy L, Silverman DN, McKenna R (2005). Structural and kinetic characterization of active-site histidine as a proton shuttle in catalysis by human carbonic anhydrase II. Biochemistry 44: 1097-1105.
Freskgard PO, Martensson LG, Jonasson P, Jonsson BH, Carlsson U (1994). Assignment of the contribution of the tryptophan residues to the circular-dichroism spectrum of human carbonic-anhydrase II. Biochemistry 33: 14281-14288.
Halder P, Taraphder S (2013). Modeling the structure and proton transfer pathways of the mutant His-107-Tyr of human carbonic anhydrase II. J Mol Model 19: 289-298.
Host GE, Jonsson BH (2008). Converting human carbonic anhydrase II into a benzoate ester hydrolase through rational redesign. Bba-Proteins Proteom 1784: 811-815.
Hunt JA, Fierke CA (1997). Selection of carbonic anhydrase variants displayed on phage - aromatic residues in zinc binding site enhance metal affinity and equilibration kinetics. J Biol Chem 272: 20364-20372.
Innocenti A, Casini A, Alcaro MC, Papini AM, Scozzafava A, Supuran CT (2004). Carbonic anhydrase inhibitors: the first on-resin screening of a 4-sulfamoylphenylthiourea library. Jo Med Chem 47: 5224-5229.
Jiang Y, Su JT, Zhang J, Wei X, Yan YB, Zhou HM (2008). Reshaping the folding energy landscape of human carbonic anhydrase II by a single point genetic mutation Pro237His. Int J Biochem Cell Biol 40: 776-788.
Kockar F, Maresca A, Aydin M, Isik S, Turkoglu S, Sinan S, Arslan O, Guler OO, Turan Y, Supuran CT (2010). Mutation of Phe91 to Asn in human carbonic anhydrase I unexpectedly enhanced both catalytic activity and affinity for sulfonamide inhibitors. Bioorgan Med Chem 18: 5498-5503.
Krebs JF, Fierke CA (1993). Determinants of catalytic activity and stability of carbonic anhydrase-II as revealed by random mutagenesis. J Biol Chem 268: 948-954.
Krebs JF, Rana F, Dluhy RA, Fierke CA (1993). Kinetic and spectroscopic studies of hydrophilic amino acid substitutions in the hydrophobic pocket of human carbonic anhydrase II. Biochemistry 32: 4496-4505.
Mete E, Comez B, Inci Gul H, Gulcin I, Supuran CT (2016). Synthesis and carbonic anhydrase inhibitory activities of new thienylsubstituted pyrazoline benzenesulfonamides. J Enzyme Inhib Med Chem 31: 1-5.
Mikulski R, Avvaru BS, Tu C, Case N, McKenna R, Silverman DN (2011a). Kinetic and crystallographic studies of the role of tyrosine 7 in the active site of human carbonic anhydrase II. Arch Biochem Biophys 506: 181-187.
Mikulski R, Domsic JF, Ling G, Tu CK, Robbins AH, Silverman DN, McKenna R (2011b). Structure and catalysis by carbonic anhydrase II: role of active-site tryptophan 5. Arch Biochem Biophys 516: 97-102.
Nair SK, Calderone TL, Christianson DW, Fierke CA (1991). Altering the mouth of a hydrophobic pocket - structure and kinetics of human carbonic anhydrase-II mutants at residue Val-121. J Biol Chem 266: 17320-17325.
Nair SK, Christianson DW (1993). Structural consequences of hydrophilic amino acid substitutions in the hydrophobic pocket of human carbonic anhydrase II. Biochemistry 32: 4506-4514.
Sastry GM, Adzhigirey M, Day T, Annabhimoju R, Sherman W (2013). Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aid Mol Des 27: 221-234.
Scott AD, Phillips C, Alex A, Flocco M, Bent A, Randall A, OBrien R, Damian L, Jones LH (2009). Thermodynamic optimisation in drug discovery: a case study using carbonic anhydrase inhibitors. ChemMedChem 4: 1985-1989.
Senturk M, Gulcin I, Beydemir S, Kufrevioglu OI, Supuran CT (2011). In vitro inhibition of human carbonic anhydrase I and II isozymes with natural phenolic compounds. Chem Biol Drug Des 77: 494-499.
Silverman DN, Lindskog S (1988). The catalytic mechanism of carbonic-anhydrase - implications of a rate-limiting protolysis of water. Accounts Chem Res 21: 30-36.
Supuran CT (2008). Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 7: 168-181.
Supuran CT, Scozzafava A (2007). Carbonic anhydrases as targets for medicinal chemistry. Bioorgan Med Chem 15: 4336-4350.
Turkoglu S, Maresca A, Alper M, Kockar F, Isik S, Sinan S, Ozensoy O, Arslan O, Supuran CT (2012). Mutation of active site residues Asn67 to Ile, Gln92 to Val and Leu204 to Ser in human carbonic anhydrase II: influences on the catalytic activity and affinity for inhibitors. Bioorgan Med Chem 20: 2208-2213.
Verpoorte JA, Mehta S, Edsall JT (1967). Esterase activities of human carbonic anhydrases B and C. J Biol Chem 242: 4221-4229.
West D, Kim CU, Tu CK, Robbins AH, Gruner SM, Silverman DN, McKenna R (2012). Structural and kinetic effects on changes in the CO2 binding pocket of human carbonic anhydrase II. Biochemistry 51: 9156-9163.
Wu MJ, Jiang Y, Yan YB (2011). Impact of the 237th residue on the folding of human carbonic anhydrase II. Int J Mol Sci 12: 2797- 2807.
Yaseen R, Ekinci D, Senturk M, Hameed AD, Ovais S, Rathore P, Samim M, Javed K, Supuran CT (2016). Pyridazinone substituted benzenesulfonamides as potent carbonic anhydrase inhibitors. Bioorg Med Chem Lett 26: 1337-1341.